Natus Medical Inc (BABY) Holdings Boosted by Ladenburg Thalmann Financial Services Inc.

Ladenburg Thalmann Financial Services Inc. raised its position in shares of Natus Medical Inc (NASDAQ:BABY) by 11.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,044 shares of the medical equipment provider’s stock after acquiring an additional 1,452 shares during the period. Ladenburg Thalmann Financial Services Inc.’s holdings in Natus Medical were worth $527,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of BABY. Aperio Group LLC boosted its holdings in shares of Natus Medical by 7.0% during the second quarter. Aperio Group LLC now owns 6,583 shares of the medical equipment provider’s stock worth $246,000 after acquiring an additional 429 shares during the period. Municipal Employees Retirement System of Michigan boosted its holdings in shares of Natus Medical by 3.2% during the second quarter. Municipal Employees Retirement System of Michigan now owns 7,760 shares of the medical equipment provider’s stock worth $289,000 after acquiring an additional 240 shares during the period. Great West Life Assurance Co. Can boosted its holdings in shares of Natus Medical by 3.0% during the second quarter. Great West Life Assurance Co. Can now owns 48,240 shares of the medical equipment provider’s stock worth $1,796,000 after acquiring an additional 1,383 shares during the period. Sei Investments Co. boosted its stake in shares of Natus Medical by 29.7% in the second quarter. Sei Investments Co. now owns 3,182 shares of the medical equipment provider’s stock valued at $119,000 after buying an additional 728 shares during the period. Finally, Arizona State Retirement System boosted its stake in shares of Natus Medical by 1.2% in the second quarter. Arizona State Retirement System now owns 17,306 shares of the medical equipment provider’s stock valued at $646,000 after buying an additional 200 shares during the period. Institutional investors own 94.39% of the company’s stock.

BABY has been the subject of several recent research reports. Zacks Investment Research upgraded Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research note on Tuesday, October 24th. BidaskClub cut Natus Medical from a “hold” rating to a “sell” rating in a research note on Saturday, December 9th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $46.50.

In other news, VP Dong Chune Christopher Chung sold 12,642 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $42.91, for a total transaction of $542,468.22. Following the completion of the transaction, the vice president now directly owns 141,414 shares in the company, valued at $6,068,074.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William M. Moore sold 5,000 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $41.01, for a total transaction of $205,050.00. The disclosure for this sale can be found here. 5.50% of the stock is owned by insiders.

Natus Medical Inc (NASDAQ:BABY) opened at $38.55 on Tuesday. Natus Medical Inc has a 1 year low of $31.65 and a 1 year high of $43.60. The company has a market cap of $1,200.99, a P/E ratio of -428.29 and a beta of 0.84. The company has a debt-to-equity ratio of 0.36, a quick ratio of 3.36 and a current ratio of 4.21.

Natus Medical (NASDAQ:BABY) last announced its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $0.40 EPS for the quarter, beating the consensus estimate of $0.38 by $0.02. Natus Medical had a negative net margin of 0.62% and a positive return on equity of 12.06%. The business had revenue of $122.60 million during the quarter, compared to the consensus estimate of $122.41 million. During the same period in the previous year, the business earned $0.39 earnings per share. The company’s revenue was up 34.9% on a year-over-year basis. equities research analysts anticipate that Natus Medical Inc will post 1.74 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Natus Medical Inc (BABY) Holdings Boosted by Ladenburg Thalmann Financial Services Inc.” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.com-unik.info/2017/12/26/natus-medical-inc-baby-holdings-boosted-by-ladenburg-thalmann-financial-services-inc.html.

Natus Medical Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Inc (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit